205 related articles for article (PubMed ID: 1479612)
1. Metabolism of platelet-activating factor in the guinea-pig heart.
Triggiani M; Chilton FH
J Mol Cell Cardiol; 1992 Oct; 24(10):1101-11. PubMed ID: 1479612
[TBL] [Abstract][Full Text] [Related]
2. Influence of immunologic activation and cellular fatty acid levels on the catabolism of platelet-activating factor within the murine mast cell (PT-18).
Triggiani M; Chilton FH
Biochim Biophys Acta; 1989 Nov; 1006(1):41-51. PubMed ID: 2572273
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of platelet-activating factor by arachidonic acid-depleted rat polymorphonuclear leukocytes.
Ramesha CS; Pickett WC
J Biol Chem; 1986 Nov; 261(33):15519-23. PubMed ID: 3096991
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
Blank ML; Spector AA; Kaduce TL; Lee TC; Snyder F
Biochim Biophys Acta; 1986 May; 876(3):373-8. PubMed ID: 3707974
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells.
Chao W; Siafaka-Kapadai A; Hanahan DJ; Olson MS
Biochem J; 1989 Jul; 261(1):77-81. PubMed ID: 2775221
[TBL] [Abstract][Full Text] [Related]
6. Factors that influence the proportions of platelet-activating factor and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine synthesized by the mast cell.
Triggiani M; Fonteh AN; Chilton FH
Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):497-503. PubMed ID: 1530582
[TBL] [Abstract][Full Text] [Related]
7. Metabolic fate of platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) in FRTL5 cells.
Botitsi E; Mavri-Vavayanni M; Siafaka-Kapadai A
J Lipid Res; 1998 Jun; 39(6):1295-304. PubMed ID: 9643362
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by an enriched preparation of the human lung mast cell.
Triggiani M; Hubbard WC; Chilton FH
J Immunol; 1990 Jun; 144(12):4773-80. PubMed ID: 2141044
[TBL] [Abstract][Full Text] [Related]
9. 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes.
Chilton FH; Ellis JM; Olson SC; Wykle RL
J Biol Chem; 1984 Oct; 259(19):12014-9. PubMed ID: 6434535
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of platelet-activating factor by rat alveolar macrophages: lyso-PAF as an obligatory intermediate in the formation of alkylarachidonoyl glycerophosphocholine species.
Robinson M; Snyder F
Biochim Biophys Acta; 1985 Oct; 837(1):52-6. PubMed ID: 4052436
[TBL] [Abstract][Full Text] [Related]
11. Catabolism of platelet-activating factor by human colonic mucosa. Calcium dependence of the catabolizing enzymes.
Appleyard CB; Hillier K
Biochem Pharmacol; 1992 Jun; 43(12):2503-9. PubMed ID: 1632809
[TBL] [Abstract][Full Text] [Related]
12. The role of platelet-activating factor-dependent transacetylase in the biosynthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by stimulated endothelial cells.
Balestrieri ML; Servillo L; Lee T
J Biol Chem; 1997 Jul; 272(28):17431-7. PubMed ID: 9211886
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
Tsoukatos DC; Liapikos TA; Tselepis AD; Chapman MJ; Ninio E
Biochem J; 2001 Jul; 357(Pt 2):457-64. PubMed ID: 11439095
[TBL] [Abstract][Full Text] [Related]
14. Biosynthesis of platelet-activating factor in glandular gastric mucosa. Evidence for the involvement of the 'de novo' pathway and modulation by fatty acids.
Fernandez-Gallardo S; Gijon MA; Garcia MC; Cano E; Sanchez Crespo M
Biochem J; 1988 Sep; 254(3):707-14. PubMed ID: 2848496
[TBL] [Abstract][Full Text] [Related]
15. Platelet activating factor degradation in tear fluid from guinea pigs with allergic conjunctivitis.
Kato M; Mano H; Ota A; Konomi K; Nakata K
J Ocul Pharmacol Ther; 2001 Feb; 17(1):83-91. PubMed ID: 11327052
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of platelet activating factor and metabolism of related lipids in embryonic cells.
Chepenik KP; Wykle RL
Biochim Biophys Acta; 1992 Jun; 1126(2):192-8. PubMed ID: 1627622
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) in exocrine glands and its control by secretagogues.
Söling HD; Fest W
J Biol Chem; 1986 Oct; 261(30):13916-22. PubMed ID: 3095313
[TBL] [Abstract][Full Text] [Related]
18. Translocation of exogenous platelet-activating factor and its lyso-compound through plasma membranes is a rate-limiting step for their metabolic conversions into alkylacylglycerophosphocholines in rabbit platelets and guinea-pig leukocytes.
Tokumura A; Tsutsumi T; Yoshida J; Tsukatani H
Biochim Biophys Acta; 1990 May; 1044(1):91-100. PubMed ID: 2340312
[TBL] [Abstract][Full Text] [Related]
19. Biosynthesis and metabolism of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine in rat glomerular mesangial cells.
Lianos EA; Zanglis A
J Biol Chem; 1987 Jul; 262(19):8990-3. PubMed ID: 3110152
[TBL] [Abstract][Full Text] [Related]
20. Evidence for different mechanisms involved in the formation of lyso platelet-activating factor and the calcium-dependent release of arachidonic acid from human neutrophils.
Winkler JD; Sung CM; Hubbard WC; Chilton FH
Biochem Pharmacol; 1992 Nov; 44(10):2055-66. PubMed ID: 1449523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
